CoraLite® Plus 488-conjugated SNX15 Monoclonal antibody
SNX15 Monoclonal Antibody for IF/ICC
Host / Isotype
Mouse / IgG2a
Reactivity
Human
Applications
IF/ICC
Conjugate
CoraLite® Plus 488 Fluorescent Dye
CloneNo.
1A10B7
Cat no : CL488-68239
Synonyms
Validation Data Gallery
Tested Applications
Positive IF/ICC detected in | U2OS cells |
Recommended dilution
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
CL488-68239 targets SNX15 in IF/ICC applications and shows reactivity with Human samples.
Tested Reactivity | Human |
Host / Isotype | Mouse / IgG2a |
Class | Monoclonal |
Type | Antibody |
Immunogen | SNX15 fusion protein Ag8839 |
Full Name | sorting nexin 15 |
Calculated Molecular Weight | 342 aa, 38 kDa |
Observed Molecular Weight | 40-50 kDa |
GenBank Accession Number | BC009897 |
Gene Symbol | SNX15 |
Gene ID (NCBI) | 29907 |
Conjugate | CoraLite® Plus 488 Fluorescent Dye |
Excitation/Emission Maxima Wavelengths | 493 nm / 522 nm |
Form | Liquid |
Purification Method | Protein A purification |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
SNX15 belongs to the sorting nexin family and is involved in several stages of intracellular trafficking. Overexpression of SNX15 results in a decrease in the processing of insulin and hepatocyte growth factor receptors to their mature subunits (PMID: 11085978). SNX15 is widely expressed, with the highest expression in skeletal muscle, heart, brain, kidney, spleen, thymus, and small intestine.
Protocols
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 SNX15 antibody CL488-68239 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |